📰 Liminal Bioscience News
Page 4 - Liminal Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Liminal Bioscience. Real-time updates on events, politics, business and more.
January 19, 2023
LAVAL, QC and CAMBRIDGE, England, Jan. 19, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive
January 19, 2023
/PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at...
January 6, 2023
/PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), is pleased to provide an overview of the Companys priorities...
January 6, 2023
Closed December 2022 with just over CAD 37 million cash on hand, expecting to provide a runway into early 2024.Plans to divest its remaining non-core assets, to further extend runway.Nominated
November 25, 2022
/PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that it will be holding a virtual special meeting...
November 25, 2022
LAVAL, QC and CAMBRIDGE, England, Nov. 25, 2022 /PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that it will be holding a virtual
November 9, 2022
$40.8M of cash and cash equivalents at September 30, 2022 Discontinuation of fezagepras development Termination of legacy CDMO agreement for cash savings of...
November 9, 2022
$40.8M of cash and cash equivalents at September 30, 2022 Discontinuation of fezagepras developmentTermination of legacy CDMO agreement for cash savings of $33.1 millionNet loss from
November 9, 2022
$40.8M of cash and cash equivalents at September 30, 2022 Discontinuation of fezagepras development Termination of legacy CDMO agreement for cash savings of...
November 9, 2022
$40.8M of cash and cash equivalents at September 30, 2022 Discontinuation of fezagepras development Termination of legacy CDMO agreement for cash savings of...